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size and results in worsened post-stroke 
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Abstract 
Background: A third of ischemic stroke cases have no traditional underlying causes such as hypertension, diabetes, 
atherosclerosis, obesity, or age. Moreover, thirty to forty percent of strokes occur during or acutely after an active 
infection and the incidence of stroke increases during flu season. We and others have shown that the combination 
of a minor bacterial infection mimic, 100 μg/kg of lipopolysaccharide (LPS) prior to a minor stroke—30 min transient 
middle cerebral artery occlusion (tMCAO)—exacerbates infarct volume in a mouse model. Thus, experimental and 
epidemiological data strongly suggest that infection and/or inflammation play a role in stroke occurrence and sever‑
ity. However, to date, long‑term outcomes of stroke during an active infection has not been studied.
Methods: 3–4 month old C57Bl6/J mice were treated with saline or LPS 30 min prior to a 30 min tMCAO or sham 
surgery. A behavioral battery was administered to assess health status/sickness behavior, neurological deficits, motor, 
cognitive, and affective behaviors.
Results: We show for the first time that exposure to a low dose of LPS prior to a mild stroke significantly worsens 
neurological deficits and sickness scores. Motor, cognitive, and affective behaviors were assessed post‑stroke and 
while stroke significantly affected motor behavior on rotarod, LPS did not increase the motor deficits. We did not 
observe any effects of stroke or LPS on cognitive and affective behaviors.
Conclusions: Our observations of the association between infection, stroke, and worse sickness and neurological 
outcomes identify (1) a clinical need to aggressively treat infections in people with risk factors for stroke and (2) the 
need to understand the mechanism(s) of the association between infections and stroke.
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Background
Stroke is the 5th leading cause of death in the United 
States and the leading cause of disability [1]. Numerous 
risk factors such as diabetes, hypertension, and athero-
sclerosis have been recognized to increase susceptibility 
to stroke; however, the epidemiology of ischemic stroke is 
not sufficiently explained by the prevalence of these cere-
brovascular risk factors [2]. In at least a third of ischemic 
stroke cases, the patients lack traditional risk factors and 
have no apparent cause. The presence of systemic infec-
tion could be an important mediating risk factor. Indeed, 
thirty to forty percent of strokes occur during or acutely 
after an infection [2] suggest an association between sys-
temic infection and stroke. Although infection has been 
implicated in increasing susceptibility to stroke, few stud-
ies have examined how an infection prior to stroke affects 
outcome. McColl et al. [3] and Doll et al. [4] found that 
administering lipopolysaccharide (LPS) 30  min prior 
to transient middle cerebral artery occlusion (tMCAO) 
resulted in an increased infarct volume. We have shown 
that a mechanism by which lipopolysaccharide (LPS) 
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exacerbates stroke damage involves an increase in blood 
brain barrier (BBB) damage through mitochondrial 
dysfunction [4] and others have suggested a cytokine-
dependent mechanism [3]. Together, these findings 
suggest an association between systemic infection and 
stroke.
While it is clear that bacterial infection prior to stroke 
can affect acute stroke damage [3, 4], to our knowl-
edge no studies have examined the long-term effects of 
a bacterial infection mimic on behavioral outcomes. 
We hypothesized that LPS administered prior to stroke 
would exacerbate the motor, cognitive, and affective 
behavioral deficits post-stroke. To test our hypothesis, 
we used an animal model of mild infection and mild 
stroke developed by McColl et al. [3], then assessed sick-
ness behavior, neurological deficits, locomotor, cognitive, 
and affective behaviors to determine if a bacterial infec-




C57/BL6 J male mice (3–4 months old, 25–30 g, Jackson 
Laboratories) were used for all studies. All procedures 
were conducted according to criteria approved by the 
Institutional Animal Care and Use Committees at the 
West Virginia University.
Randomization and blinding of the animal experiments
To assign groups (Vehicle Sham, LPS Sham, Vehi-
cle Stroke, LPS Stroke), we numbered the animals and 
applied a simple randomization by using excel-generated 
random numbers. To avoid biases, we also assured that 
sham and stroke surgeries along with the different treat-
ments (LPS or vehicle) were performed on the same day. 
The experimenters were blinded to the pre-treatments 
and data analysis.
Drug administration
LPS (Escherichia coli 055:B5, 100  μg/kg, Sigma) dis-
solved in saline (B. Braun Medical Inc. Irvine, California) 
was administered via an intraperitoneal injection 30 min 
prior to tMCAO or sham surgery. An equal volume of 
saline was administered to vehicle treated mice.
Ischemic model and sham surgery
We performed focal cerebral ischemia for 30  min by 
occlusion of the right middle cerebral artery with a 6.0 
monofilament suture (Doccol, Sharon, Massachusetts). 
All surgical anesthesia was induced with 4–5  % isoflu-
rane until the animal showed no response to a toe pinch, 
and was maintained with 1–2 % isoflurane via face-mask 
in O2-enriched air. We used laser Doppler flowmetry 
(Moor instruments, United Kingdom) to detect regional 
cerebral blood flow and confirm a successful occlusion 
(>70  % decrease in flow). Rectal body temperature was 
maintained at 37 ± 0.5 °C during surgery. One cohort of 
mice was euthanized at 48 h post-stroke to assess infarct 
area, and a separate cohort was euthanized at the end of 
the behavioral battery.
Analysis of brain infarct area: cohort 1
In one cohort, a total of 28 mice (N  =  7/group) were 
euthanized with isoflurane 48  h post-ischemia. We 
removed the brains and cut 2 mm coronal sections with 
a mouse brain matrix. We stained the sections with 2 % 
2,3,5-triphenyltetrazolium chloride (TTC, Sigma, Saint 
Louis, Missouri) in phosphate buffer solution (PBS) at 
37  °C for 30  min then fixed the tissue in 10  % formalin 
phosphate buffer for digital photograph. We analyzed 
the digitized image of each brain section using comput-
erized image analysis software (ImageJ, NIH) in a dou-
ble-blinded manner. Additional data from this cohort of 
animals was published in Doll et al. [4].
Behavioral test battery: cohort 2
In another cohort, a total of 40 mice (Vehicle Sham = 10; 
LPS Sham = 10; Vehicle Stroke = 10; LPS Stroke = 10) 
underwent behavioral testing. Two animals were 
excluded from the LPS stroke group; one due to post-
mortem evidence of cerebral hemorrhage, and a second 
due to a surgery complication. The animal excluded due 
to a surgery complication was replaced resulting in an 
n = 9 for the LPS stroke group. The animals were treated 
and assessed in two cohorts with n = 5 in each group for 
each cohort. We selected the following behavioral tests to 
assess a range of affective, locomotor, and cognitive abili-
ties and to identify and control for potential locomotor, 
visual, or motivational alterations effected by stroke and 
bacterial infection prior to stroke. Figure  1 depicts the 
time-course of behavioral testing. All animals underwent 
the entire test battery with the exception of Morris water 
maze. The first cohort showed no significant effects or 
trends toward a treatment or surgery effect on this test; 
thus, we did not subject the second cohort of animals to 
Morris water maze testing. However, the timing post-
stroke of the other behavioral assessments were main-
tained constant across cohorts. All testing was completed 
during the light cycle (0800–1500) by the same experi-
menter, who was blind to treatment group status. Central 
air conditioning fans provided white noise in the test-
ing room. Between each animal, the behavior apparatus 
was cleaned of debris with Virkon and, when appropriate 
(Open Field, Elevated Plus Maze), 50 % ethanol.
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Health and sickness behavior screen
Overall health and sickness behavior was assesses using 
an objective 20 point screen developed in our labora-
tory. The health screen was administered daily by the 
same experimenter who was blind to treatment group 
status. The screen encompasses seven physical domains 
designed to provide insight into the global physical 
health of an animal. The screen was designed to be rapid 
and easy to administer, to be minimally invasive, and 
to ensure consistency in scoring across the post-stroke 
recovery period. To assess health status and sickness 
behavior, the animal was observed in its home cage for 
general appearance, posture, respiration, and spontane-
ous locomotion/social interaction. Body condition (ema-
ciation and hydration) was assessed by the pinch test. 
Body temperature and body weight were also measured 
(see Additional file 1: Table S1 for scoring criteria). The 
screen was administered twice prior to tMCAO and each 
day post-tMCAO for 7 days between 0800 and 0930.
Modified Neurological Severity Score (mNSS)
The mNSS, adapted from Chen et al. [5], assessed neuro-
logic function on a scale of 0–12 with 0 being normal and 
12 being maximal deficit (see Additional file 1: Table S2 
for scoring criteria). The mNSS used here was composed 
of motor and balance tests; the reflex test was eliminated 
due to habituation of the mice after repeat testing. mNSS 
scores were determined twice prior to tMCAO and each 
day post-tMCAO for 7 days between 0800 and 0930.
Cylinder test
The cylinder test evaluates spontaneous forelimb use and 
asymmetries resulting from neural injury [6]. The animal 
was placed in a transparent cylinder (12 cm wide, 19 cm 
tall) for 5 min and allowed to freely explore. Performance 
was video recorded for later assessment. The number of 
independent wall placements for the right and left fore-
limbs, in addition to placement of both forelimbs simul-
taneously, were recorded. Cylinder test performance was 
conducted twice prior to tMCAO to account for pre-
operative handedness biases, as well as 1, 3, 5 and 7 days 
post-tMCAO.
Open field
This task evaluates locomotor activity and emotional reac-
tivity [7]. A white plastic box (60 cm × 60 cm × 15 cm) 
was placed upon a table. Five desk lamps (60 watt each) 
provided indirect illumination. At the start of the trial, 
each mouse was placed in arena at the midpoint of the 
South wall and received a 6 min session. Locomotor activ-
ity was recorded using Ethovision 8.5 (Noldus Informa-
tion Technology, Wageningenm, The Netherlands). For 
analysis, the box floor was divided into inner zone, mid-
dle frame, and perimeter zones. The dependent variables 
were fecal boli excreted, and distance moved (cm) in the 
arena as well as distance moved (cm) in each zone.
Elevated plus maze
This task assesses anxiety-like behavior in a novel envi-
ronment, with mice spending less time in open arms 
considered ‘anxious’ [8]. Two intersecting arm pairs were 
arranged in a ‘plus’ configuration and elevated 60  cm 
from the floor. One arm pair, 58 cm long × 5 cm wide, 
was enclosed by walls 15 cm tall and the other arm pair 
remained open (no walls or edges). Room illumination 
consisted of ambient lighting. Each mouse was placed at 
the arm intersection point and allowed to freely explore 
for 5 min. The dependent variables were the frequency of 
entries into each arm pair, the time spent (s) in the open 
arm pair, and the number of fecal boli excreted.
Fig. 1 Timeline schematic of treatment, surgery and behavioral testing
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Visible platform
This task confirms visual and motor competence for 
water maze testing [9]. A circular tub (140 cm in diam-
eter) was filled with clear water. A white- and black-
colored platform with a white/black flag was positioned 
approximately 0.5 cm above the water surface in a fixed 
location within the pool. Blue curtains covered obvious 
extra maze cues. The drop-off location varied semi-ran-
domly across trials. Each mouse had 90  s to locate the 
platform, where it remained for 15 s before being placed 
back into its heated cage. If an animal did not locate 
the platform within the allotted time limit, it was gen-
tly guided to the platform. Between animals, the maze 
was cleaned of debris and olfactory cues were disrupted 
using a fishnet. The inter-trial interval was approxi-
mately 12 min. Latency (s) to reach the platform was the 
dependent measure.
Morris water maze
Acquisition The Morris water maze tests hippocampal-
dependent spatial reference memory [10], memory for 
information that remains consistent across time [11]. 
A round tub (140 cm in diameter) was filled with room 
temperature water made opaque with non-toxic paint. 
Spatial cues (shelving, door, striped posters, etc.) were 
indirectly lit. Briefly, the mouse was placed in the maze 
from any of four locations (North, South, East, or West) 
and had 60  s to locate a hidden platform submerged 
1  cm, which remained in a fixed location (Northwest 
quadrant; NW). If an animal failed to locate the plat-
form, it was gently guided to the platform. After 15  s 
on the platform, the mouse was placed into its heated 
cage until the next trial. Between animals, the maze 
was cleaned of debris and olfactory cues. There was 
approximately a 15 min inter-trial interval between tri-
als. A tracking system (Ethovision XT 8.5) analyzed each 
mouse’s swim path. Animals received 4 trials for 6 days. 
The dependent measure was swim distance (cm). Swim 
speed (cm/s) was assessed to determine possible loco-
motor differences.
Probe Trial To assess platform localization, on the 6th 
day of testing an additional probe trial was given (trial 
5), whereby the platform was removed from the maze. 
Percent of total swim distance (cm) in the target NW 
quadrant (i.e., quadrant that once contained the plat-
form) versus the opposite Southeast (SE) quadrant and 
frequency of platform zone crossings were the dependent 
measure [12].
Reversal To assess cognitive flexibility/perseveration 
[13], reversal learning was assessed the following day, 
whereby the platform was relocated to the SE quadrant. 
Animals received 4 trials for 2 days, with a 15 min delay 
between trials three and four. Trial 5 was a probe trial on 
day 2. All testing procedures were identical to the Morris 
water maze acquisition and probe testing.
Accelerating rotarod
This task assesses locomotor performance and coordina-
tion. A textured plastic horizontal rod (3 cm in diameter) 
was mounted 14.5  cm above a pressure-sensitive base 
(Ugo Basile). Acceleration was set to 4–44 rpm in 300 s 
[14]. For a given trial, a mouse was placed on the rod and 
the motor and timer switch were activated. Acceleration 
continued until the mouse fell onto the padded base or 
until 300 s had elapsed. Animals received 4 trials per ses-
sion, with an inter-trial interval of 20 min, and two ses-
sions per day, with an inter-session interval of 1  h, for 
4 days. Latency to fall (s) was the dependent variable.
Modified porsolt forced swim test
This test assesses depressive-like behavioral despair [15]. 
A plastic cylinder (19 cm tall, 12 cm wide) was filled up 
to a height of 10.5 cm with 25 °C water. Each animal was 
tested for 6  min. Following each trial, the animal was 
removed, dried with paper towels, and warmed in cages 
heated with a heat pad. The water was changed after each 
trial. Behavior was video recorded and quantified by a 
blind observer who scored each animal as either engag-
ing in (1) active escape behaviors (swimming, climbing, 
and diving) or (2) immobility (floating or minimally mov-
ing). Behavior of each animal during the first 2 min was 
not included. Latency (s) to first immobility, total time (s) 
spent immobile, and number of fecal boli excreted were 
the dependent variables.
Statistical analysis
Statistical analyses were performed with Statview. Dif-
ferences between groups were analyzed by the unpaired 
Student’s t test, two-way ANOVA or a repeated measure 
two-way ANOVA as appropriate for each outcome meas-
ure (indicated in the figure legends).
Results
Infarct area
Low dose bacterial infection mimic administered 30 min 
prior to a mild (30  min) tMCAO increased cortical 
infarct area (p < 0.05) and caudate/putamen infarct area 
(p  <  0.05) (Fig.  2). We measured rectal temperature at 
0, 6, 12, 18, 24, and 48  h post-stroke to ensure that the 
increase in infarct volume was not due to an increase in 
temperature after stroke, and this data was reported in 
Doll et  al. [4] Stroke alone caused a modest decline in 
rectal temperature, while LPS + stroke caused a marked 
hypothermia post-stroke [4]. These data indicate that the 
observed increase in infarct volume caused by the com-
bination of LPS and tMCAO was not due to a febrile 
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response. As such, we then conducted assessments in an 
additional cohort of mice for the effects of LPS on the 
behavioral outcomes of stroke.
Modified Neurological Severity Score
To assess functional neurological damage, the modi-
fied neurological severity score (mNSS) adapted from 
Chen et al. [5] was administered for 7 days post-surgery. 
Prior to surgery, the mNSS was administered to assess 
baseline biases, and animals in all 4 groups scored simi-
larly (p = 0.6652; F [1, 35] = 0.1904). Overall there was 
a day  ×  treatment (p  =  0.0067; F [1, 35]  =  2.875) and 
day × surgery interaction (p < 0.0001; F [1, 35] = 13.603). 
Upon visual inspection of the graph, the stroke and 
LPS effect diminished over time resulting in the effect 
of surgery or treatment being exacerbated in the acute 
recovery phase (days 1–3) (Fig.  3), but in the sub-acute 
recovery phase (days 4–6), mNSS scores returned to 
baseline levels. This rapid recovery after an insult in mice 
has been noted previously [16, 17]. Thus, we blocked the 
data by acute recovery phase (days 1–3) and sub-acute 
recovery phase (days 4–6) to determine the effect of 
treatment, surgery, and their interaction on neurological 
deficits. During the first 3  days post-surgery, there was 
an overall treatment × surgery interaction (p = 0.0454; F 
[1, 35] =  4.304) indicating that LPS worsens neurologi-
cal deficits post-stroke. However, during the sub-acute 
recovery phase the treatment ×  surgery interaction was 
Fig. 2 LPS exacerbates infarct area. Cortical and Caudate/Putamen infarct area. A student’s t‑test between control and treatment group showed a 
significant increase in cortical infarct area (p = 0.0488) and caudate/putamen infarct area (p = 0.0134). Depicted are mean ± SEM for 7 mice/group. 
*p < 0.05
Fig. 3 Stroke and Stroke + LPS exacerbate neurological deficits. A 
two way repeated measures ANOVA showed a significant day by 
treatment (p = 0.0067) and day by surgery effect (p < 0.0001). When 
blocking the data, day 1–3 (acute phase recovery) and day 4–6 (sub‑
acute phase recovery), there was a significant treatment by surgery 
interaction (0.0454) during the acute phase of recovery. This signifi‑
cant treatment by surgery interaction was lost during the sub‑acute 
phase of recovery. Depicted are mean ± SEM for 9–10 mice/group. 
When SEM is not shown, it is smaller than the symbol used to depict 
the mean. *p < 0.05
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not observed (p = 0.7531; F [1, 35] = 0.101), but the Sur-
gery effect remained (p < 0.005; F [1, 35] = 11.6).
Health and sickness behavior screen
Prior to tMCAO (time point 0), the animals in all four 
groups had a health screen score of 0 indicating that all 
animals were healthy animals at the time of treatment 
administration and/or stroke surgery (Fig.  4). Overall, 
there was a day × treatment (p < 0.005; F [1, 35] = 4.112) 
and a day  ×  surgery interaction (p  <  0.0001; F [1, 
35]  =  6.552). Upon visual inspection of the graph, the 
surgery and treatment effects were diminished over time, 
similarly to the mNSS. Thus, we blocked the data by acute 
recovery phase (days 1–3) and sub-acute recovery phase 
(days 4–6) to determine the effect of treatment, surgery, 
and the interaction on sickness behavior. Overall there 
were no interactions between stroke and LPS during the 
acute or sub-acute recovery phase. During both block of 
days there was a significant surgery effect (p < 0.0001; F 
[1, 35] =  63.974); however, only during the acute phase 
was there a significant treatment effect (p < 0.0005; F [1, 
35] =  14.828). By the sub-acute recovery, the treatment 
effect diminished (p = 0.0842; F [1, 35] = 3.160), but the 
Surgery effect remained (p < 0.0001; F [1, 35] = 22.655).
Motor function
To assess motor function, performance on the accelerat-
ing rotarod was assessed 11 ± 1 days post-surgery. There 
was a significant stroke effect resulting in decreased 
motor function (p  <  0.005; Fig.  5). This effect of stroke 
surgery on motor function was not due to decreased 
locomotor activity because open field indicated no dif-
ferences between the groups (Table 1). To assess forelimb 
functional asymmetries, the cylinder task was adminis-
tered. Before surgery (day 0), there were no differences 
between groups on rearing (Fig.  6) nor on left versus 
right forelimb placement (data not shown). There was an 
overall day × surgery effect (p < 0.0001; F [1, 35] = 8.916) 
post-surgery (Fig.  6); thus, we further investigated the 
effect of surgery on each day. There was a significant Sur-
gery effect (p  <  0.0005; F [1,35] =  15.23) on rearing on 
day 1, indicating that animals that had undergone stroke 
(regardless of drug treatment) were less active than ani-
mals who received sham surgery. By day 3, the surgery 
effect diminished. This finding of depressed locomotor 
behavior (as measured by overall number or rears) limits 
the interpretation of paw placement findings.
Affective behaviors
Stroke nor LPS impacted general locomotor ability nor 
anxiety-like behavior in the open field (Table  1). There 
were no significant group differences in distance moved 
in any zone during the 6  min trial (Table  1). Similarly, 
stroke nor LPS impacted anxiety-like behavior on the 
elevated plus maze. There were no group differences in 
Fig. 4 Stroke induces sickness behavior. A two way repeated 
measures ANOVA showed a significant day by treatment (p = 0.0006) 
and day by surgery effect (p < 0.0001). When blocking the data, day 
1–3 (acute phase recovery) and day 4–6 (sub‑acute phase recovery), 
there was a significant day by surgery effect (p < 0.0001). Depicted 
are mean ± SEM for 9–10 mice/group. When SEM is not shown, 
it is smaller than the symbol used to depict the mean. **p < 0.01; 
***p < 0.001
Fig. 5 Stroke increases motor dysfunction. A two way repeated 
measures ANOVA showed a significant surgery effect (p = 0.0011). 
Depicted are mean ± SEM for 9–10 mice/group. **p < 0.01
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the number of open arm entries, number of closed arm 
entries, or the time (s) spent in the open arms (data not 
shown). Moreover, neither stroke nor LPS impacted 
depressive-like behavior on the forced swim test. There 
were no significant treatment effects on total time spent 
immobile, or latency to first immobility (data not shown).
Discussion
Recent studies have indicated that both Helicobac-
ter pylori (H. pylori) [18] and human cytomegalovirus 
(HCMV) [19] infections are associated with increased 
risk for ischemic stroke. Moreover, having a respiratory 
tract infection increases the risk for an atherothrombotic 
ischemic event for up to 3 months [20] and chronic bron-
chitis increases risk for stroke and transient ischemic 
attacks (TIA) [21]. Lastly, Grabska et al. [22] conducted 
a retrospective chart review of 2066 ischemic stroke 
patients to assess the effect of pre-stroke and post-stroke 
infection on ischemic stroke severity and found that pre-
stroke infection increased poor outcomes within the first 
30 days but did not have effects at 90 days on modified 
Rankin scores. From a preclinical perspective, LPS has 
been shown to increase infarct volume when admin-
istered prior to MCAO in rodents [3, 4]. However, the 
long-term effects of stroke during an active infection 
have not been studied previously. The present study 
shows for the first time that low dose LPS increases and 
prolongs sickness behavior and worsens neurological def-
icits post-stroke. Thus, infection appears to both trigger 
and worsen severity of stroke.
It is known that a severe stroke results in motor, cog-
nitive, and affective behavioral deficits [16, 23–26]. Fur-
ther, studies have shown that high doses of LPS causes 
motor, cognitive, and affective deficits [27–32]. However, 
until the current study, the long-term functional out-
comes of stroke in combination with an active infection 
had not been methodically assessed in the rodent model. 
We hypothesized that the LPS administered prior to 
stroke would exacerbate the motor, cognitive, and affec-
tive behavioral deficits post-stroke. Our most robust 
effects of low dose LPS + mild stroke were on lesion vol-
ume, mNSS and sickness. The hypothermic response to 
LPS +  stroke could be an adaptive protective response, 
because in other studies, we observed that mainte-
nance of core body temperature following LPS +  stroke 
resulted in profound sickness and death of mice (Doll 
et  al., unpublished observations) and that acute post-
stroke hypothermia is strongly associated with larger 
infarct size in mice (Heng et  al., unpublished observa-
tions). The LPS +  stroke effects on mNSS and sickness 
peaked at 1  day after stroke, then recovered over the 
7-day observation period, indicating that acute behavio-
ral response to LPS + stroke is transient, as has been pre-
viously reported for stroke alone in rodents and humans 
[6, 22]. We also showed that stroke, but not LPS treat-
ment, affects balance and motor coordination during the 
accelerating rotarod task. As well, we did not observe 
effects of stroke, LPS, or their combination on open field, 
Table 1 Stroke or LPS does not have an effect on locomotor ability in open field
Reported are mean ± standard error of mean for total distance moved (cm), center duration (s), inner duration (s), and outer duration (s) during the open field task for 
each group
Group Total distance (cm) Center duration (s) Inner duration (s) Outer duration (s)
Vehicle sham 2295 ± 231 5 ± 2 15 ± 3 340 ± 5
LPS sham 2384 ± 208 5 ± 1 12 ± 3 343 ± 5
Vehicle stroke 2521 ± 257 5 ± 1 16 ± 5 339 ± 6
LPS stroke 2553 ± 232 6 ± 1 16 ± 2 338 ± 3
Fig. 6 Stroke decreases rearing in the cylinder task. A two way 
repeated measures ANOVA showed a significant day by surgery effect 
(p < 0.0001). Further investigation of each day indicated a significant 
effect of surgery on day 1 (p = 0.0004) but by day 3 there was no 
effect of surgery or treatment. Depicted are mean ± SEM for 9–10 
mice/group. **p < 0.01; ***p < 0.001
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elevated plus maze or forced swim. Taken together, we 
demonstrate for the first time that an infection, present at 
the time of brain trauma (induced by MCAO) can exac-
erbate detrimental stroke outcomes, negatively impacting 
health and significantly prolonging recovery.
Limitations of the present study are several. We did not 
observe some of the previously reported behavioral defi-
cits that have been found following MCAO or LPS among 
rodents. This is most likely due to methodological differ-
ences between our work and previous studies including 
(1) the timing of post-manipulation assessments, (2) the 
severity of the model of brain insult used here, and (3) 
the low dose of LPS used in our study. Indeed, it is well 
recognized that there are critical periods for detecting 
post-stroke deficits [6]. As well, many studies assessing 
functional outcomes following LPS assessed performance 
within hours of treatment administration. Thus, we may 
have not seen LPS + stroke effects in some behaviors due 
to the timing of assessment. Also, severity of the stroke 
insult may have influenced our ability to detect functional 
deficits. Our stroke was a 30 min tMCAO, which is con-
sidered a minor insult, and caused a small infarct (Fig. 2). 
The low dose of LPS used here, and thus the severity 
of the infection induced at the time of stroke also may 
explain why we did not observe substantial detrimental 
behavioral changes. Although others have shown that 
LPS results in motor, cognitive, and affective behavioral 
deficits, the doses used ranged from 0.3–10 mg/kg which 
are 3–100 times higher than the dose used in the present 
study. Additionally, a few studies injected LPS multiple 
times before assessing behavior [30]; thus, the single, low 
LPS dose given in this study likely resulted in a minor 
bacterial infection mimic, and the chosen battery of func-
tional assessments may have not been sensitive enough to 
detect a mild impairment at the time points at which they 
were administered. Future studies should assess different 
doses of LPS and determine the time to assess different 
behavioral deficits. Furthermore, an increase prevalence 
of strokes occurs during flu season. Here, we utilized 
LPS, a bacterial infection mimic. However, it is not clear 
whether the exacerbation of post-stroke functional defi-
cits by LPS found here extend to other types of infection. 
Thus, the assessment of the effects of a viral infection 
mimic prior to stroke on functional outcome is needed.
This study was not designed to assess the mechanism(s) 
of the interaction between LPS and stroke, but rather to 
describe the consequences of this interaction on lesion 
volume, neurological deficits, sickness and behavio-
ral outcomes. There are several potential mechanisms 
by which LPS could exacerbate stroke outcome. LPS 
itself is neurotoxic [33], and increases levels of sev-
eral neurotoxic cytokines, including TNFα [3]. We have 
shown that TNFα causes neuronal loss by inhibition of 
mitochondrial oxidative phosphorylation [34]. Addition-
ally, LPS compromised the blood–brain barrier (BBB) 
[4]. As such, through either or both mechanisms, treat-
ment with low doses of LPS may sensitize animals to the 
subsequent effects of a mild stroke and thereby worsen 
outcomes.
Thus, we can conclude from this study that a minor 
bacterial infection mimic prior to a minor stroke results 
in increased infarct area, increased sickness behav-
ior and worse neurological deficits resulting in delayed 
functional recovery. Our observations of the association 
between infection, stroke, and worse sickness and neuro-
logical outcomes argues for the need to aggressively treat 
infection in people with risk factors for stroke and the 
need to understand the mechanism(s) of this association.
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